234 related articles for article (PubMed ID: 26346319)
21. Binding of natively unfolded HIF-1alpha ODD domain to p53.
Sánchez-Puig N; Veprintsev DB; Fersht AR
Mol Cell; 2005 Jan; 17(1):11-21. PubMed ID: 15629713
[TBL] [Abstract][Full Text] [Related]
22. Regulation of hypoxia-inducible factor 1α (HIF-1α) by lysophosphatidic acid is dependent on interplay between p53 and Krüppel-like factor 5.
Lee SJ; No YR; Dang DT; Dang LH; Yang VW; Shim H; Yun CC
J Biol Chem; 2013 Aug; 288(35):25244-25253. PubMed ID: 23880760
[TBL] [Abstract][Full Text] [Related]
23. [The expression of HIF-1alpha in scars and its relationship to apoptosis].
Li GF; Tan J; Zhong Q; Luo CQ; Liu XY
Zhonghua Zheng Xing Wai Ke Za Zhi; 2006 Mar; 22(2):113-5. PubMed ID: 16736613
[TBL] [Abstract][Full Text] [Related]
24. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha.
An WG; Kanekal M; Simon MC; Maltepe E; Blagosklonny MV; Neckers LM
Nature; 1998 Mar; 392(6674):405-8. PubMed ID: 9537326
[TBL] [Abstract][Full Text] [Related]
25. HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation.
Nardinocchi L; Puca R; D'Orazi G
Aging (Albany NY); 2011 Jan; 3(1):33-43. PubMed ID: 21248371
[TBL] [Abstract][Full Text] [Related]
26. Reduction of HIF-1α/PD-L1 by Catalytic Topoisomerase Inhibitor Induces Cell Death Through Caspase Activation in Cancer Cells Under Hypoxia.
Miyata S; Ishii T; Kitanaka S
Anticancer Res; 2024 Jan; 44(1):49-59. PubMed ID: 38159998
[TBL] [Abstract][Full Text] [Related]
27. Understanding complexity in the HIF signaling pathway using systems biology and mathematical modeling.
Fábián Z; Taylor CT; Nguyen LK
J Mol Med (Berl); 2016 Apr; 94(4):377-90. PubMed ID: 26821588
[TBL] [Abstract][Full Text] [Related]
28. [The relationship between P53 and hypoxia-inducible transcription factor-1alpha in the placenta of patient with intrahepatic cholestasis of pregnancy under acute hypoxic condition].
Hu YY; Wang XD; Liu SY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Nov; 37(6):901-3, 942. PubMed ID: 17236590
[TBL] [Abstract][Full Text] [Related]
29. HIF-1alpha and p53 as targets of NO in affecting cell proliferation, death and adaptation.
Zhou J; Schmid T; Brüne B
Curr Mol Med; 2004 Nov; 4(7):741-51. PubMed ID: 15579021
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.
Rohwer N; Cramer T
Drug Resist Updat; 2011 Jun; 14(3):191-201. PubMed ID: 21466972
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor-1α protects cervical carcinoma cells from apoptosis induced by radiation via modulation of vascular endothelial growth factor and p53 under hypoxia.
Fu Z; Chen D; Cheng H; Wang F
Med Sci Monit; 2015 Jan; 21():318-25. PubMed ID: 25623525
[TBL] [Abstract][Full Text] [Related]
32. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
[TBL] [Abstract][Full Text] [Related]
33. Tight control of hypoxia-inducible factor-α transient dynamics is essential for cell survival in hypoxia.
Bagnall J; Leedale J; Taylor SE; Spiller DG; White MR; Sharkey KJ; Bearon RN; Sée V
J Biol Chem; 2014 Feb; 289(9):5549-64. PubMed ID: 24394419
[TBL] [Abstract][Full Text] [Related]
34. Transcription factor YY1 contributes to tumor growth by stabilizing hypoxia factor HIF-1α in a p53-independent manner.
Wu S; Kasim V; Kano MR; Tanaka S; Ohba S; Miura Y; Miyata K; Liu X; Matsuhashi A; Chung UI; Yang L; Kataoka K; Nishiyama N; Miyagishi M
Cancer Res; 2013 Mar; 73(6):1787-99. PubMed ID: 23328582
[TBL] [Abstract][Full Text] [Related]
35. Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors.
Blagosklonny MV
Oncogene; 2001 Jan; 20(3):395-8. PubMed ID: 11313969
[TBL] [Abstract][Full Text] [Related]
36. Effects of lentivirus-mediated HIF-1alpha knockdown on hypoxia-related cisplatin resistance and their dependence on p53 status in fibrosarcoma cells.
Hao J; Song X; Song B; Liu Y; Wei L; Wang X; Yu J
Cancer Gene Ther; 2008 Jul; 15(7):449-55. PubMed ID: 18421307
[TBL] [Abstract][Full Text] [Related]
37. Protein phosphatase 1 nuclear targeting subunit is a hypoxia inducible gene: its role in post-translational modification of p53 and MDM2.
Lee SJ; Lim CJ; Min JK; Lee JK; Kim YM; Lee JY; Won MH; Kwon YG
Cell Death Differ; 2007 Jun; 14(6):1106-16. PubMed ID: 17318220
[TBL] [Abstract][Full Text] [Related]
38. Expression of hypoxia-inducible factor 1alpha in epithelial ovarian tumors: its impact on prognosis and on response to chemotherapy.
Birner P; Schindl M; Obermair A; Breitenecker G; Oberhuber G
Clin Cancer Res; 2001 Jun; 7(6):1661-8. PubMed ID: 11410504
[TBL] [Abstract][Full Text] [Related]
39. Pretreatment evaluation of combined HIF-1alpha, p53 and p21 expression is a useful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer.
Sohda M; Ishikawa H; Masuda N; Kato H; Miyazaki T; Nakajima M; Fukuchi M; Manda R; Fukai Y; Sakurai H; Kuwano H
Int J Cancer; 2004 Jul; 110(6):838-44. PubMed ID: 15170665
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of HIF-1alpha by oncolytic reovirus infection independently of VHL and p53.
Cho IR; Koh SS; Min HJ; Park EH; Ratakorn S; Jhun BH; Jeong SH; Yoo YH; Youn HD; Johnston RN; Chung YH
Cancer Gene Ther; 2010 May; 17(5):365-72. PubMed ID: 20075985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
